CHICAGO, Oct. 16 /PRNewswire/ — Allscripts Healthcare Solutions
(Nasdaq: MDRX) Physicians Interactive(TM) (PI) business unit, announced today
that it will be providing interactive product education — also known as
e-Detailing(TM) — to physicians on behalf of AstraZeneca (NYSE: AZN).
AstraZeneca is one of the top five pharmaceutical companies in the world with
leading positions in sales of gastrointestinal, oncology, anesthesia
(including pain management), cardiovascular, central nervous system (CNS) and
PI, with one-third of the top U.S. pharmaceutical companies as clients, is
the leading provider of interactive healthcare product education for
physicians and healthcare professionals. PI recruits physicians for its
clients’ customized, ten-minute product education sessions. Physicians can
access programs via the Internet or through an interactive voice response
(IVR) system, 24 hours a day, 7 days a week.
“We chose Physicians Interactive to conduct this program to assist us in
delivering a complete, consistent educational message to physicians when it is
most convenient to them,” commented Jennifer Ogorzalek, Senior ePromotions
PI created the concept of e-Detailing and has logged more than 50,000
physician sessions in the last twelve months alone. In fact, more than two-
thirds of all electronic details ever completed have been on a PI platform.
“We are very excited to have this opportunity to work with AstraZeneca,”
commented Aaron Gerber, MD, MBA, General Manager for the Physicians
Interactive business unit. “Ensuring that physicians have the most up-to-date
and accurate information about the medications they prescribe benefits the
patient, the physician, and the pharmaceutical company.”
About Allscripts Healthcare Solutions
Allscripts Healthcare Solutions is the leading provider of point-of-care
decision support solutions for physicians. The Company’s TouchWorks software
products enhance physician productivity and are accessed using a wireless
handheld or desktop workstation to automate the most common physician
activities including prescribing, dictating, capturing charges, ordering labs
and viewing results, providing patient education, and taking clinical notes.
Additionally, Allscripts provides patient compliance and healthcare product
education services for physicians through its Physicians Interactive unit.
Allscripts provides services to over 15,000 physicians at more than 4,000
sites across the U.S.Strategic partners include IDX Systems (Nasdaq: IDXC);
IMS Health (NYSE: RX); Express Scripts (Nasdaq: ESRX); Compaq (NYSE: CPQ);
Merck-Medco; and Microsoft (Nasdaq: MSFT).
Physicians Interactive and e-Detailing are trademarks of Allscripts
Healthcare Solutions. Visit Allscripts on the Web at allscripts.com or
Physicians Interactive at www.e-detailing.com .
This announcement may contain forward-looking statements about Allscripts
Healthcare Solutions that involve risks and uncertainties. These statements
are developed by combining currently available information with Allscripts
beliefs and assumptions. Forward-looking statements do not guarantee future
performance. Because Allscripts cannot predict all of the risks and
uncertainties that may affect it, or control the ones it does predict,
Allscripts’ actual results may be materially different from the results
expressed in its forward-looking statements. For a more complete discussion
of the risks, uncertainties and assumptions that may affect Allscripts see the
Company’s 2000 Annual Report on Form 10-K, available through the Web site
maintained by the Securities and Exchange Commission at www.sec.gov .
AstraZeneca (NYSE: AZN) is a major international healthcare business
engaged in the research, development, manufacture and marketing of ethical
(prescription) pharmaceuticals and the supply of healthcare services. It is
one of the top five pharmaceutical companies in the world with healthcare
sales of $15.8 billion and leading positions in sales of gastrointestinal,
oncology, anesthesia (including pain management), cardiovascular, central
nervous system (CNS) and respiratory products. In the United States,
AstraZeneca is an $8 billion healthcare business with more than 10,000
For more information about AstraZeneca please visit
MAKE YOUR OPINION COUNT - Click Here http://tbutton.prnewswire.com/prn/11690X67654494
SOURCE Allscripts Healthcare Solutions
CONTACT: Dan Michelson, Vice President of Marketing of Allscripts
Healthcare Solutions, +1-800-654-0889, Ext. 4330, or